Sputnik V

Sputnik Light, the Single Dose Version of Sputnik V Authorized in Russia

Yesterday, 6th April 2021, the Russian Ministry of Health, the Gamaleya National Research Center of Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announced that Sputnik Light, a single dose COVID-19 vaccine, has received authorization for use in Russia.

Sputnik Light, the Single Dose Version of Sputnik V Authorized in Russia Read More

Sputnik V; the Russian Weapon Against the COVID 19 Pandemic

Sputnik V vaccine, a product of Russian Research facility, Gamaleya Research Institute of Epidemiology and Microbiology is one of the main vaccination candidate Sri Lanka is looking forward to acquire in mass scale. The first consignment of Sputnik V Vaccine with 15000 doses arrived in Sri Lanka yesterday, 4th May 2021. According to state officials Sri Lanka is to receive 13 million doses of this Sputnik V vaccine in near future.

Sputnik V; the Russian Weapon Against the COVID 19 Pandemic Read More
RT-LAMP by SLINTEC

SLINTEC Obtains NMRA GMP License for Their COVID Test Kit, Commercial Manufacturing to Commence Soon

In a special press release today, 1st of May 2021 the Sri Lanka Institute of Nanotechnology (SLINTEC) announced obtaining the GMP license from NMRA for manufacturing their COVID 19 Rapid Test Kit RT-LAMP.

SLINTEC Obtains NMRA GMP License for Their COVID Test Kit, Commercial Manufacturing to Commence Soon Read More
b.1.1.7

COVID Variant B.1.1.7: Some Key Facts You Should Know

In a special announcement today the scientists at Sri Jayewardenepura University revealed the COVID 19 virus strain behind the recent increase of the cases to be the variant B.1.1.7 which was first identified in United Kingdom during the month September 2020. According to the observations in UK this variant was found to be associated with increased admissibility and higher virulance.

COVID Variant B.1.1.7: Some Key Facts You Should Know Read More
COVID 19 Conference

NSF to Organize a National Conference on “COVID -19: Impact, Mitigation, Opportunities and Building Resilience”

Early this week, National Science Foundation of Sri Lanka announced a proposal for a National Level conference on “COVID -19: Impact, Mitigation, Opportunities and Building Resilience” under the theme “From Adversity to Serendipity” in January 2021.

NSF to Organize a National Conference on “COVID -19: Impact, Mitigation, Opportunities and Building Resilience” Read More
Vitamin D

Vitamin D determines severity in COVID-19: Irish research

A recent research conducted by a team in Triniy Collage, Dublin, Ireland shows a possible involvement of Vitamin D levels of Covid 19 patients towards low mortality rates. The team had done this study using Vitamin D data available online about the European countries affected by COVID 19 and the Covid 19 mortality rates of those countries as reported by WHO.

Vitamin D determines severity in COVID-19: Irish research Read More